Estimates of the proportion of older white men who would be recommended for pharmacologic treatment by the new US national osteoporosis foundation guidelines

Meghan G. Donaldson, Peggy M. Cawthon, Lily Y. Lui, John T. Schousboe, Kristine E. Ensrud, Brent C. Taylor, Jane A. Cauley, Teresa A. Hillier, Thuy T. Dam, Jeff R. Curtis, Dennis M. Black, Douglas C. Bauer, Eric Orwoll, Steven R. Cummings

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

The new US National Osteoporosis Foundation's (NOF's) Clinician's Guide to Prevention and Treatment of Osteoporosis includes criteria for recommending pharmacologic treatment based on history of hip or vertebral fracture, femoral neck or spine bone mineral density (BMD) T-scores of -2.5 or less, and presence of low bone mass at the femoral neck or spine plus a 10-year risk of hip fracture of 3% or greater or of major osteoporotic fracture of 20% or greater. The proportion of men who would be recommended for treatment by these guidelines is not known. We applied the NOF criteria for treatment to men participating in the Osteoporotic Fractures in Men Study (MrOS). To determine how the MrOS population differs from the general US population of Caucasian men aged 65 years and older, we compared men in MrOS with men who participated in the National Health and Nutrition Examination Survey (NHANES) III on criteria included in the NOF treatment guidelines that were common to both cohorts. Compared with NHANES III, men in MrOS had higher femoral neck BMD values. Application of NOF guidelines to MrOS data estimated that at least 34% of US white men aged 65 years and older and 49% of those aged 75 years and older would be recommended for drug treatment. Application of the new NOF guidelines would result in recommending a very large proportion of white men in the United States for pharmacologic treatment of osteoporosis, for many of whom the efficacy of treatment is unknown.

Original languageEnglish (US)
Pages (from-to)1506-1511
Number of pages6
JournalJournal of Bone and Mineral Research
Volume25
Issue number7
DOIs
StatePublished - Jul 2010

Fingerprint

Osteoporosis
Guidelines
Osteoporotic Fractures
Therapeutics
Nutrition Surveys
Femur Neck
Bone Density
Spine
Femoral Neck Fractures
Hip Fractures
Population
Hip
Bone and Bones
Pharmaceutical Preparations

Keywords

  • Bone density
  • Epidemiology
  • Guidelines
  • Men
  • Osteoporosis
  • Treatment

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Estimates of the proportion of older white men who would be recommended for pharmacologic treatment by the new US national osteoporosis foundation guidelines. / Donaldson, Meghan G.; Cawthon, Peggy M.; Lui, Lily Y.; Schousboe, John T.; Ensrud, Kristine E.; Taylor, Brent C.; Cauley, Jane A.; Hillier, Teresa A.; Dam, Thuy T.; Curtis, Jeff R.; Black, Dennis M.; Bauer, Douglas C.; Orwoll, Eric; Cummings, Steven R.

In: Journal of Bone and Mineral Research, Vol. 25, No. 7, 07.2010, p. 1506-1511.

Research output: Contribution to journalArticle

Donaldson, MG, Cawthon, PM, Lui, LY, Schousboe, JT, Ensrud, KE, Taylor, BC, Cauley, JA, Hillier, TA, Dam, TT, Curtis, JR, Black, DM, Bauer, DC, Orwoll, E & Cummings, SR 2010, 'Estimates of the proportion of older white men who would be recommended for pharmacologic treatment by the new US national osteoporosis foundation guidelines', Journal of Bone and Mineral Research, vol. 25, no. 7, pp. 1506-1511. https://doi.org/10.1002/jbmr.55
Donaldson, Meghan G. ; Cawthon, Peggy M. ; Lui, Lily Y. ; Schousboe, John T. ; Ensrud, Kristine E. ; Taylor, Brent C. ; Cauley, Jane A. ; Hillier, Teresa A. ; Dam, Thuy T. ; Curtis, Jeff R. ; Black, Dennis M. ; Bauer, Douglas C. ; Orwoll, Eric ; Cummings, Steven R. / Estimates of the proportion of older white men who would be recommended for pharmacologic treatment by the new US national osteoporosis foundation guidelines. In: Journal of Bone and Mineral Research. 2010 ; Vol. 25, No. 7. pp. 1506-1511.
@article{934bb752ef61473da6a8c418c4c59d74,
title = "Estimates of the proportion of older white men who would be recommended for pharmacologic treatment by the new US national osteoporosis foundation guidelines",
abstract = "The new US National Osteoporosis Foundation's (NOF's) Clinician's Guide to Prevention and Treatment of Osteoporosis includes criteria for recommending pharmacologic treatment based on history of hip or vertebral fracture, femoral neck or spine bone mineral density (BMD) T-scores of -2.5 or less, and presence of low bone mass at the femoral neck or spine plus a 10-year risk of hip fracture of 3{\%} or greater or of major osteoporotic fracture of 20{\%} or greater. The proportion of men who would be recommended for treatment by these guidelines is not known. We applied the NOF criteria for treatment to men participating in the Osteoporotic Fractures in Men Study (MrOS). To determine how the MrOS population differs from the general US population of Caucasian men aged 65 years and older, we compared men in MrOS with men who participated in the National Health and Nutrition Examination Survey (NHANES) III on criteria included in the NOF treatment guidelines that were common to both cohorts. Compared with NHANES III, men in MrOS had higher femoral neck BMD values. Application of NOF guidelines to MrOS data estimated that at least 34{\%} of US white men aged 65 years and older and 49{\%} of those aged 75 years and older would be recommended for drug treatment. Application of the new NOF guidelines would result in recommending a very large proportion of white men in the United States for pharmacologic treatment of osteoporosis, for many of whom the efficacy of treatment is unknown.",
keywords = "Bone density, Epidemiology, Guidelines, Men, Osteoporosis, Treatment",
author = "Donaldson, {Meghan G.} and Cawthon, {Peggy M.} and Lui, {Lily Y.} and Schousboe, {John T.} and Ensrud, {Kristine E.} and Taylor, {Brent C.} and Cauley, {Jane A.} and Hillier, {Teresa A.} and Dam, {Thuy T.} and Curtis, {Jeff R.} and Black, {Dennis M.} and Bauer, {Douglas C.} and Eric Orwoll and Cummings, {Steven R.}",
year = "2010",
month = "7",
doi = "10.1002/jbmr.55",
language = "English (US)",
volume = "25",
pages = "1506--1511",
journal = "Journal of Bone and Mineral Research",
issn = "0884-0431",
publisher = "Wiley-Blackwell",
number = "7",

}

TY - JOUR

T1 - Estimates of the proportion of older white men who would be recommended for pharmacologic treatment by the new US national osteoporosis foundation guidelines

AU - Donaldson, Meghan G.

AU - Cawthon, Peggy M.

AU - Lui, Lily Y.

AU - Schousboe, John T.

AU - Ensrud, Kristine E.

AU - Taylor, Brent C.

AU - Cauley, Jane A.

AU - Hillier, Teresa A.

AU - Dam, Thuy T.

AU - Curtis, Jeff R.

AU - Black, Dennis M.

AU - Bauer, Douglas C.

AU - Orwoll, Eric

AU - Cummings, Steven R.

PY - 2010/7

Y1 - 2010/7

N2 - The new US National Osteoporosis Foundation's (NOF's) Clinician's Guide to Prevention and Treatment of Osteoporosis includes criteria for recommending pharmacologic treatment based on history of hip or vertebral fracture, femoral neck or spine bone mineral density (BMD) T-scores of -2.5 or less, and presence of low bone mass at the femoral neck or spine plus a 10-year risk of hip fracture of 3% or greater or of major osteoporotic fracture of 20% or greater. The proportion of men who would be recommended for treatment by these guidelines is not known. We applied the NOF criteria for treatment to men participating in the Osteoporotic Fractures in Men Study (MrOS). To determine how the MrOS population differs from the general US population of Caucasian men aged 65 years and older, we compared men in MrOS with men who participated in the National Health and Nutrition Examination Survey (NHANES) III on criteria included in the NOF treatment guidelines that were common to both cohorts. Compared with NHANES III, men in MrOS had higher femoral neck BMD values. Application of NOF guidelines to MrOS data estimated that at least 34% of US white men aged 65 years and older and 49% of those aged 75 years and older would be recommended for drug treatment. Application of the new NOF guidelines would result in recommending a very large proportion of white men in the United States for pharmacologic treatment of osteoporosis, for many of whom the efficacy of treatment is unknown.

AB - The new US National Osteoporosis Foundation's (NOF's) Clinician's Guide to Prevention and Treatment of Osteoporosis includes criteria for recommending pharmacologic treatment based on history of hip or vertebral fracture, femoral neck or spine bone mineral density (BMD) T-scores of -2.5 or less, and presence of low bone mass at the femoral neck or spine plus a 10-year risk of hip fracture of 3% or greater or of major osteoporotic fracture of 20% or greater. The proportion of men who would be recommended for treatment by these guidelines is not known. We applied the NOF criteria for treatment to men participating in the Osteoporotic Fractures in Men Study (MrOS). To determine how the MrOS population differs from the general US population of Caucasian men aged 65 years and older, we compared men in MrOS with men who participated in the National Health and Nutrition Examination Survey (NHANES) III on criteria included in the NOF treatment guidelines that were common to both cohorts. Compared with NHANES III, men in MrOS had higher femoral neck BMD values. Application of NOF guidelines to MrOS data estimated that at least 34% of US white men aged 65 years and older and 49% of those aged 75 years and older would be recommended for drug treatment. Application of the new NOF guidelines would result in recommending a very large proportion of white men in the United States for pharmacologic treatment of osteoporosis, for many of whom the efficacy of treatment is unknown.

KW - Bone density

KW - Epidemiology

KW - Guidelines

KW - Men

KW - Osteoporosis

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=77954724087&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954724087&partnerID=8YFLogxK

U2 - 10.1002/jbmr.55

DO - 10.1002/jbmr.55

M3 - Article

VL - 25

SP - 1506

EP - 1511

JO - Journal of Bone and Mineral Research

JF - Journal of Bone and Mineral Research

SN - 0884-0431

IS - 7

ER -